American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ASTRAZENECA PLC

$181.55 -2.37% NYSE: AZN · 15-min delayed

Public · NYSE: AZN
96,100 employees
Founded 1913

Visit website Follow

$288.4BMarket cap

96,100Employees

AZNNYSE

2009IPO

About ASTRAZENECA PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Founded: 1913
Type: Public · NYSE: AZN
Employees: 96,100
IPO date: Oct 23, 2009
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: AZN NYSE
SEC CIK: 901832
LEI: PY6ZZQWO2IZFZC3IOL08
SIC: 2834 Pharmaceutical Preparations

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow ASTRAZENECA PLC and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Market cap: $288.4B

NYSE: AZN

$181.55 -2.37%

15-minute delayed · data by Polygon.io

Past year

$66.23 $209.48

52-week range

Market cap: $288.4B
Dividend yield: 1.76%
Shares outstanding: 1.6B
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Oct 23, 2009

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

Trading 13% below its 52-week high.
Pays a dividend yielding about 1.76% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.